Lin YS, Zhang X, Wang C, Liu YQ, et al. Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer. J Clin Endocrinol Metab 2021 Mar 26. pii: 6189101. doi: 10.1210.
PMID: 33769497